Efficacy and tolerability of pharmacotherapy for post-stroke depression: a network meta-analysis

BACKGROUND: Post-stroke depression (PSD) occurs in approximately one third of stroke survivors, leading to great disability and mortality. As there is no consensus on the optimal pharmacological treatment for PSD, we aimed to evaluate the relative efficacy and tolerability of the available pharmacol...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Linghui, Qiu, Shi, Yang, Yan, Wang, Lu, Li, Yuxiao, Lin, Jing, Wei, Qiang, Yang, Lu, Wang, Deren, Liu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955092/
https://www.ncbi.nlm.nih.gov/pubmed/29805769
http://dx.doi.org/10.18632/oncotarget.23891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955092/
https://www.ncbi.nlm.nih.gov/pubmed/29805769
http://dx.doi.org/10.18632/oncotarget.23891

Ejemplares similares